Chunling Qin

发表

Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection

Yuxin Chen, Liusong Yin, Xiao-li Feng, 2023, Antibody therapeutics.